These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8168806)

  • 1. Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine).
    Trefz F; de Sonneville L; Matthis P; Benninger C; Lanz-Englert B; Bickel H
    Hum Genet; 1994 Apr; 93(4):369-74. PubMed ID: 8168806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated ingestion of aspartame-sweetened beverage: effect on plasma amino acid concentrations in individuals heterozygous for phenylketonuria.
    Stegink LD; Filer LJ; Baker GL; Bell EF; Ziegler EE; Brummel MC; Krause WL
    Metabolism; 1989 Jan; 38(1):78-84. PubMed ID: 2909831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high-protein meal plus aspartame ingestion on plasma phenylalanine concentrations in obligate heterozygotes for phenylketonuria.
    Curtius HC; Endres W; Blau N
    Metabolism; 1994 Apr; 43(4):413-6. PubMed ID: 8159095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated ingestion of aspartame-sweetened beverages: further observations in individuals heterozygous for phenylketonuria.
    Stegink LD; Filer LJ; Bell EF; Ziegler EE; Tephly TR; Krause WL
    Metabolism; 1990 Oct; 39(10):1076-81. PubMed ID: 2215254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspartame-sweetened beverage: effect on plasma amino acid concentrations in normal adults and adults heterozygous for phenylketonuria.
    Stegink LD; Wolf-Novak LC; Filer LJ; Bell EF; Ziegler EE; Krause WL; Brummel MC
    J Nutr; 1987 Nov; 117(11):1989-95. PubMed ID: 2890728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects.
    Filer LJ; Stegink LD
    Diabetes Care; 1989 Jan; 12(1):67-74. PubMed ID: 2653751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma amino acid levels after single-dose aspartame consumption in phenylketonuria, mild hyperphenylalaninemia, and heterozygous state for phenylketonuria.
    Caballero B; Mahon BE; Rohr FJ; Levy HL; Wurtman RJ
    J Pediatr; 1986 Oct; 109(4):668-71. PubMed ID: 3761084
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease.
    Hertelendy ZI; Mendenhall CL; Rouster SD; Marshall L; Weesner R
    Am J Gastroenterol; 1993 May; 88(5):737-43. PubMed ID: 8480740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an aspartame loading test for the detection of heterozygotes for classical phenylketonuria.
    Silva LC; Pires RF; Coelho JC; Jardim LB; Giugliani R
    Clin Genet; 1997 Apr; 51(4):231-5. PubMed ID: 9184243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of repeated ingestion of aspartame-sweetened beverage on plasma amino acid, blood methanol, and blood formate concentrations in normal adults.
    Stegink LD; Filer LJ; Bell EF; Ziegler EE; Tephly TR
    Metabolism; 1989 Apr; 38(4):357-63. PubMed ID: 2566887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma phenylalanine levels in phenylketonuric heterozygous and normal adults administered aspartame at 34 mg/kg body weight.
    Stegink LD; Koch R; Blaskovics ME; Filer LJ; Baker GL; McDonnell JE
    Toxicology; 1981; 20(1):81-90. PubMed ID: 7268794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspartame: neuropsychologic and neurophysiologic evaluation of acute and chronic effects.
    Spiers PA; Sabounjian L; Reiner A; Myers DK; Wurtman J; Schomer DL
    Am J Clin Nutr; 1998 Sep; 68(3):531-7. PubMed ID: 9734727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aspartame loading upon plasma and erythrocyte amino acid levels in phenylketonuric heterozygotes and normal adult subjects.
    Stegink LD; Filer LJ; Baker GL; McDonnell JE
    J Nutr; 1979 Apr; 109(4):708-17. PubMed ID: 430270
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of long-term large doses of aspartame.
    Leon AS; Hunninghake DB; Bell C; Rassin DK; Tephly TR
    Arch Intern Med; 1989 Oct; 149(10):2318-24. PubMed ID: 2802896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropsychiatric effects of aspartame in normal volunteers.
    Lapierre KA; Greenblatt DJ; Goddard JE; Harmatz JS; Shader RI
    J Clin Pharmacol; 1990 May; 30(5):454-60. PubMed ID: 2347957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspartame: review of safety.
    Butchko HH; Stargel WW; Comer CP; Mayhew DA; Benninger C; Blackburn GL; de Sonneville LM; Geha RS; Hertelendy Z; Koestner A; Leon AS; Liepa GU; McMartin KE; Mendenhall CL; Munro IC; Novotny EJ; Renwick AG; Schiffman SS; Schomer DL; Shaywitz BA; Spiers PA; Tephly TR; Thomas JA; Trefz FK
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 2):S1-93. PubMed ID: 12180494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dietary aspartame on plasma concentrations of phenylalanine and tyrosine in normal and homozygous phenylketonuric patients.
    Mackey SA; Berlin CM
    Clin Pediatr (Phila); 1992 Jul; 31(7):394-9. PubMed ID: 1617863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspartame ingestion with and without carbohydrate in phenylketonuric and normal subjects: effect on plasma concentrations of amino acids, glucose, and insulin.
    Wolf-Novak LC; Stegink LD; Brummel MC; Persoon TJ; Filer LJ; Bell EF; Ziegler EE; Krause WL
    Metabolism; 1990 Apr; 39(4):391-6. PubMed ID: 2182973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartame is no more likely than placebo to cause urticaria/angioedema: results of a multicenter, randomized, double-blind, placebo-controlled, crossover study.
    Geha R; Buckley CE; Greenberger P; Patterson R; Polmar S; Saxon A; Rohr A; Yang W; Drouin M
    J Allergy Clin Immunol; 1993 Oct; 92(4):513-20. PubMed ID: 8409113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartame.
    Hjelle JJ; Dudley RE; Marietta MP; Sanders PG; Dickie BC; Brisson J; Kotsonis FN
    Pharmacology; 1992; 44(1):48-60. PubMed ID: 1553388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.